NCT06918912
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06918912
Title Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure (LORELY)
Acronym LORELY
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Clinico Humanitas
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo RECRUITING Alessandria ALESSANDRIA 15121 Italy Details
Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola RECRUITING Bologna BO 40138 Italy Details
Azienda Sanitaria Ospedaliera Santa Croce e Carle di Cuneo RECRUITING Cuneo Cuneo 12100 Italy Details
Ospedale San Raffaele RECRUITING Milan MILANO 20132 Italy Details
Istituto Nazionale dei Tumori RECRUITING Milan MILANO 20133 Italy Details
Irccs Istituto Clinico Humanitas RECRUITING Rozzano MILANO 20089 Italy Details
AOU Policlinico Umberto I RECRUITING Roma RO 00161 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field